KarinCA Tuesday, 06/04/19 06:17:35 PM Re: 236T568 post# 6530 Post # of 6555 Correct... It's an article, not a press release. I first saw this on the FDA site. But, it's still unrelated to ISCO since different types of stem cells are used along with different methods. Just like not all tech is the same. Not all stem cells are the same. ISCO has a type of stem cell technology that should eliminate most issues facing stem cell companies. It's a tough nut to crack since most stem cell therapies cause enough harm that they are too risky.... that's why so many are out of business. Go to ISCO site and read about how they derive their stem cells. It will be interesting to see final results of the Parkinson trial. Dilution has been the main problem here. To follow KarinCA, click here then click "Follow This Member" under my photo. Be kinder than necessary, for everyone you meet is fighting some kind of battle.